Faes Farma, S.A. (BME:FAE)
Spain · Delayed Price · Currency is EUR 4.510
+0.025 (0.56%)
At close: Mar 18, 2026
Faes Farma Market Cap
Faes Farma has a market cap or net worth of €1.4 billion as of March 18, 2026. Its market cap has increased by 32.26% in one year.
Market Cap
1.40B
Enterprise Value
1.71B
Revenue
626.99M
Ranking
n/a
PE Ratio
17.76
Stock Price
€4.51
Market Cap Chart
Since March 1, 1994, Faes Farma's market cap has increased from 163.59M to 1.40B, an increase of 758.09%. That is a compound annual growth rate of 6.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 1.40B | -12.60% |
| Dec 31, 2025 | 1.61B | 48.28% |
| Dec 31, 2024 | 1.08B | 9.15% |
| Dec 29, 2023 | 992.31M | -7.61% |
| Dec 30, 2022 | 1.07B | 5.44% |
| Dec 30, 2021 | 1.02B | 3.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.66B |
| Laboratorios Farmaceuticos Rovi | 4.04B |
| Almirall | 2.44B |
| Pharma Mar | 1.36B |
| Clínica Baviera | 816.94M |
| Oryzon Genomics | 218.59M |
| Prim, S.A. | 211.85M |
| Atrys Health | 210.93M |